Spectromics Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $150K

  • Investors
  • 4

Spectromics General Information

Description

Developer of a diagnostic technology designed to assist in the fight against growing levels of microbial resistance to antibiotics. The company's technology offers simple, accurate, and cost-effective point-of-prescription tests for bacterial infections that identify anti-microbial susceptibility and resistance during a patient appointment as well as provide guidance on the effective treatment for a particular pathogen and which drug to prescribe, enabling healthcare professionals to eliminate ineffective empirical prescriptions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 46 Grafton Street
  • Manchester M13 9NT
  • England, United Kingdom
+44 01580 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spectromics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2016 $150K 00.000 Completed Generating Revenue
1. Early Stage VC 29-Jun-2015 00.000 00.000 Completed Generating Revenue
To view Spectromics’s complete valuation and funding history, request access »

Spectromics Patents

Spectromics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3110963-B1 A method of analysing a sample including a microorganism of interest Active 26-Feb-2014 00000000
GB-201503209-D0 A method of analysing a sample including a microorganism of interest Inactive 26-Feb-2014 00000000
GB-2523668-A A method of analysing a sample including a microorganism of interest Inactive 26-Feb-2014 00000000 0
GB-201403376-D0 A method of analysing a sample including a microorganism of interest Inactive 26-Feb-2014 00000000
US-10570436-B2 Method of analysing a sample including a microorganism of interest Active 26-Feb-2014 C12Q1/18 0
To view Spectromics’s complete patent history, request access »

Spectromics Executive Team (2)

Name Title Board Seat Contact Info
Royston Goodacre Ph.D Founding Director
Matthew Upton Co-Founder & Board Member
To view Spectromics’s complete executive team members history, request access »

Spectromics Board Members (3)

Name Representing Role Since
Ian George Ph.D Self Board Member 000 0000
Matthew Upton Spectromics Co-Founder & Board Member 000 0000
Neil Butler Self Board Member 000 0000
To view Spectromics’s complete board members history, request access »

Spectromics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
Douglas Kell Angel (individual) Minority 000 0000 000000 0
MTI Partners Venture Capital Minority 000 0000 000000 0
New Wave Ventures Venture Capital Minority 000 0000 000000 0
To view Spectromics’s complete investors history, request access »